The First International Conference on the Transition from Herbal Medicines to Botanical Drugs
Thu, Oct 29
|Nanjing
Jointly hosted by the American Botanical Drug Association, China Pharmaceutical University, and the Institute of Chinese Medicine of China, this symposium fosters strategic cooperation and advancements in global botanical drug development.
Time & Location
Oct 29, 2026, 8:00 AM – 3:00 PM GMT+8
Nanjing, Nanjing, Jiangsu, China
About the event
The conference consists of a one-day intensive program featuring keynote speakers and technical sessions. This will be followed by a two-day local tour (October 30–31), providing exclusive access to premier Traditional Chinese Medicine (TCM) manufacturing facilities and world-class research institutions.
Join global industry leaders and academic researchers as we bridge the gap between traditional wisdom and modern botanical drug development.
This International Conference is dedicated to advancing the global botanical drug landscape through the following pillars:
Facilitating Global Collaboration: Bridging the gap between the biopharmaceutical and herbal medicine sectors by convening industry executives, academic researchers, and regulatory experts.
Navigating Regulatory Pathways: Addressing the technical advancements and specific challenges required to transform traditional herbal medicines into FDA-approved botanical drugs for the U.S. market.
Driving Innovation: Exploring the latest research in bioprocessing, quality control, and clinical trial methodologies for botanical products.